Cognitive & Nootropic

Adalank

Adamantane-Selank · Adamantyl-Selank

Adamantane-modified Selank analog — the Selank twin of Adamax. Search volume exists; dedicated papers do not. Parent Selank evidence does not transfer to an adamantyl conjugate. Treat half-life and dose as vendor folklore.

Not FDA-approved — research chemical
Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Low1 peer-reviewed citation
Typical research dose
200-750 mcg/day (intranasal; vendor protocols only)
Frequency
1-2× daily (intranasal)
Half-life
Unknown
Common vials
5 mg / 10 mg
CAS
N/A
Dose it
5 mg + 5 mL BAC water → 1 mg/mL · 200 mcg ≈ 20 units (U-100)
Open in calculator

Mechanism of Action

Adalank is marketed as adamantane-conjugated Selank — the Selank twin of Adamax. Adamantane can raise lipophilicity. Transferring Selank’s GABA/enkephalin papers onto this conjugate without PK is a category error.

We list it because vendors sell it and people search it. Half-life on this page is explicitly unknown.

Source: Parent Selank PMID: 18577768. Adalank: no indexed human PK as of 2026.

No published human PK

Dose and duration numbers on vendor pages are not citations. Read Selank. Treat this as an uncharacterized analog, like Adamax.

Dosing Protocol

Typical Dose200-750 mcg/day (intranasal; vendor protocols only)
Frequency1-2× daily (intranasal)
Half-LifeUnknown (no published human PK)
Common Vial Sizes5 mg, 10 mg

Dosing Protocols

Vendor nasal range only

Dose
200–750 mcg/day
Frequency
1–2× daily
Note: Folklore. Not a label.

Administration

Route
Intranasal (typical SKU)
Timing
Not established.
Fasting Required?
No — food timing not critical

Expected Timeline

Unknown
Do not copy Selank onset onto Adalank.

Who Is It For?

Nootropic analog SKU

Low

High search, near-zero papers. Listed for identity and recon, not endorsement.

Reconstitution Example

Vial
5 mg
Diluent
5 mL
Concentration
1 mg/mL
Per Unit (100u syringe)
10 mcg
Dose of 200 mcg = 20 units on a 100-unit insulin syringe
🧮 Calculate Your Exact Adalank Dose →

Safety & Considerations

Unknown human safety file. Nasal irritation possible. Adamantane moieties have CNS/renal baggage in other drugs — not characterized here.

Regulatory & Legal Status

FDA Status (US)
Research Only

Adamantane-Selank analog. No indexed human PK or approval

WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Adalank vs. Adamax

AttributeAdalankAdamax
ParentSelank (tuftsin analog)Semax (ACTH 4–10 analog)
Human PKNone indexedNone indexed
ModificationAdamantane conjugate (vendor)Adamantane conjugate (vendor)

Verdict: Twins on a catalog, both uncharacterized. Read the parent (Selank vs Semax), not the adamantane prefix.

Dosing Quick Reference

Adalank— Dosing Guide
Dose Range
200-750 mcg/day (intranasal; vendor protocols only)
Half-Life
Unknown (no published human PK)
Frequency
1-2× daily (intranasal)
Route
Subcutaneous
5 mg vial10 mg vial
💧 5 mL BAC water📐 1 mg/mL💉 10 mcg/unit (100u syringe)
Cognitive & Nootropiccalcmypeptide.com

Frequently Asked Questions

Is Adalank the same as Adamax?▼
No. Adalank is the Selank conjugate. Adamax is the Semax conjugate. Both lack human PK.

References

  1. Seredenin lineage “Selank parent literature (not Adalank).” Russian clinical literature (2008). PMID: 18577768

Looking for a trusted source? See our recommended suppliers →

Independently tested · COA-verified · Save 10% with our exclusive code

← Back to Peptide Library